Molecular Basis of Human VH Gene Replacement

  • Zhang, Zhixin, (PI)

Project: Research project

Description

DESCRIPTION(provided by applicant): The candidate is a molecular biologist who
wishes to establish an independent research career in the molecular immunology
field. Enhanced training under Dr. Max D. Cooper?s supervision in immunology is
proposed for the initial two or three years in order to achieve research
independence within the award period. The proposal will focus on the molecular
basis and regulatory mechanism of human VH gene replacement and its
contribution to normal B cell development, B cell responses, and rheumatoid
arthritis in particular. The hypothesis builds on an analysis of a clonal human
cell line, EU12, that undergoes continuous in vitro differentiation from proB
(CD34+) to preB (CD34 mu SLC+) then to B cells (CD34 mu+LC) and generates
intraclonal diversity through serial VH replacements. The ongoing VH
replacement in the EU12 cells is verified by the detection of VH replacement
excision circles and double stranded DNA breaks at the cryptic RSS sites. (Aim
1) The EU12 cells will be used as an experimental model to dissect the
molecular basis for the VH replacement. Purified RAG 1, RAG 2, and HMG 1
proteins will be used in in vitro studies to define the function of the cryptic
RSS site. (Aim 2) Using the methods and principles derived from the study of
the EU 12 model, normal human bone marrow and tonsillar germinal center B
lineage cells will be used to investigate the occurrence and stage(s) of VH
replacement in humans. (Aim 3) The regulatory mechanism of VH replacement will
be investigated using the EU12 model through evaluating the effects of. (i)
modulating surrogate light chain (lamda 5/14. 1) or conventional light chain
(kappa and lamdaX) expression, (iii) ligating cell surface receptors (pre BCR,
BCR, and CD40), and (iii) stimulating with cytokines (IL 1 beta, TFNaphla, IL
6, and IL 7) on VH replacement. (Aim 4) Determine if VH replacement occurs in
synovial B cells thereby contributing to the generation of autoantibodies and
to search for potential VH replacement stimuli in rheumatoid arthritis synovial
tissue.
StatusFinished
Effective start/end date9/1/028/31/07

Funding

  • National Institutes of Health: $70,200.00
  • National Institutes of Health: $70,200.00
  • National Institutes of Health: $70,200.00
  • National Institutes of Health: $70,200.00
  • National Institutes of Health: $70,200.00

Fingerprint

B-Lymphocytes
Genes
Surrogate Immunoglobulin Light Chains
HMGB2 Protein
Interleukin-7
Germinal Center
Double-Stranded DNA Breaks
Cell Surface Receptors
Allergy and Immunology
Interleukin-1beta
Autoantibodies
Interleukin-6
Rheumatoid Arthritis
Theoretical Models
Bone Marrow
Cytokines
Light
Research
In Vitro Techniques

ASJC

  • Medicine(all)